hydroxyurea has been researched along with Congenital Icthyosis Mental Retardation Spasticity Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sarret, C | 1 |
| Pichard, S | 1 |
| Afenjar, A | 1 |
| Boespflug-Tanguy, O | 1 |
| Willemsen, MA | 2 |
| Rotteveel, JJ | 2 |
| Steijlen, PM | 2 |
| Heerschap, A | 1 |
| Mayatepek, E | 2 |
| Lutt, MA | 1 |
| Cruysberg, JR | 1 |
| van der Graaf, M | 1 |
| Nijhuis-van der Sanden, MW | 1 |
| Pasman, JW | 1 |
3 other studies available for hydroxyurea and Congenital Icthyosis Mental Retardation Spasticity Syndrome
| Article | Year |
|---|---|
Lack of Long-Term Neurologic Efficacy of Zileuton in Sjögren-Larsson's Syndrome.
Topics: Adolescent; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Hydroxyurea; Infant; Lipoxyg | 2017 |
5-Lipoxygenase inhibition: a new treatment strategy for Sjögren-Larsson syndrome.
Topics: Aldehyde Oxidoreductases; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Fem | 2000 |
Clinical and biochemical effects of zileuton in patients with the Sjögren-Larsson syndrome.
Topics: Adolescent; Adult; Brain; Electroencephalography; Female; Humans; Hydroxyurea; Lipoxygenase Inhibito | 2001 |